Trinsicon Trademark Details

Trinsicon was registered on Tuesday, June 8, 1954 and is currently owned by Ucb Pharma, Inc. under the registration number 590763 . This mark is dead with a status of Cancelled - Section 8. The last case file activity for this mark occured 8 years ago on Friday, April 1, 2016, according to the United State Patent & Trademark Office
Word Mark Trinsicon
Status Dead Registered 710 — Cancelled - Section 8

Current Owner

Ucb Pharma, Inc. of Smyrna, GA

View all trademarks for Ucb Pharma, Inc.
Other Trademarks for Ucb Pharma, Inc.

Previous Owners

Eli Lilly and Company of Indianapolis, IN

View all trademarks for Eli Lilly and Company
Other Trademarks for Eli Lilly and Company

Ucb Phip, Inc. of Wilmington, DE

View all trademarks for Ucb Phip, Inc.
Other Trademarks for Ucb Phip, Inc.

Whitby Pharmaceuticals, Inc. of Richmond, VA

View all trademarks for Whitby Pharmaceuticals, Inc.
Other Trademarks for Whitby Pharmaceuticals, Inc.
Serial Number 71654412
Registration Number 590763
Status Date Friday, April 1, 2016
Filing Date Friday, April 1, 2016
Registration Date Tuesday, June 8, 1954
Attorney Kaushal R Odedra

Correspondent

Ray Thomas, Jr.
Wenderoth, Lind & Ponack, L.L.P.
Suite 400 East
1030 15th Street N.W.
Washington DC 20005

Case File Statements

Goods & Services Medicinal Preparation of Hematinic Concentrate with Intrinsic Factor Used in the Treatment of Anemia

Classifications

International Class Codes
005 — Class 5 includes mainly pharmaceuticals and other preparations for medical or veterinary purposes.
U.S. Class Codes 018
Status 2 — Sec. 8 – Entire Registration
Status Date Friday, April 1, 2016
First Use Anywhere Monday, September 28, 1953
First Use In Commerce Monday, September 28, 1953
Primary Code 018

You must be signed in to print.

Once signed in, look for the PDF button.